OSIRIS THERAPEUTICS INC NEW's ticker is OSIR and the CUSIP is 68827R108. A total of 67 filers reported holding OSIRIS THERAPEUTICS INC NEW in Q2 2014. The put-call ratio across all filers is 3.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $177,000 | -11.1% | 34,825 | 0.0% | 0.12% | -11.6% |
| Q1 2016 | $199,000 | -44.9% | 34,825 | 0.0% | 0.14% | -45.7% |
| Q4 2015 | $361,000 | -43.9% | 34,825 | 0.0% | 0.25% | -34.7% |
| Q3 2015 | $643,000 | -5.2% | 34,825 | 0.0% | 0.39% | +8.4% |
| Q2 2015 | $678,000 | +10.8% | 34,825 | 0.0% | 0.36% | +14.7% |
| Q1 2015 | $612,000 | +5.9% | 34,825 | -3.6% | 0.31% | -2.2% |
| Q4 2014 | $578,000 | +28.2% | 36,125 | +0.8% | 0.32% | +11.1% |
| Q3 2014 | $451,000 | -19.5% | 35,825 | 0.0% | 0.29% | -25.6% |
| Q2 2014 | $560,000 | +53.4% | 35,825 | +29.0% | 0.39% | +46.0% |
| Q1 2014 | $365,000 | -13.9% | 27,775 | +5.3% | 0.26% | -21.8% |
| Q4 2013 | $424,000 | -1.6% | 26,375 | +1.9% | 0.34% | -14.0% |
| Q3 2013 | $431,000 | +105.2% | 25,875 | +24.0% | 0.39% | +95.0% |
| Q2 2013 | $210,000 | – | 20,875 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cloverdale Capital Management, LLC | 324,722 | $6,170,000 | 3.39% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 1,233,589 | $23,437,000 | 0.77% |
| Beryl Capital Management LLC | 220,189 | $4,184,000 | 0.77% |
| BERKLEY W R CORP | 109,601 | $2,082,000 | 0.44% |
| WATER ISLAND CAPITAL LLC | 514,970 | $9,784,000 | 0.27% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 91,411 | $1,737,000 | 0.22% |
| DELTEC ASSET MANAGEMENT LLC | 50,000 | $950,000 | 0.21% |
| Versor Investments LP | 113,905 | $2,164,000 | 0.21% |
| ALGERT GLOBAL LLC | 14,774 | $281,000 | 0.16% |
| Hillsdale Investment Management Inc. | 92,941 | $1,766,000 | 0.16% |